Lemonade, INC

Market Movers (8-K)

See all →
NYSE
Lemonade, Inc. has entered into a $250 million financing agreement with Hannover Re to support customer acquisition and marketing growth through 2028.
Capital raise
NYSE
Lemonade, Inc. announced the results of its 2026 annual meeting, where shareholders re-elected two directors and approved executive compensation.
NYSE
Lemonade, Inc. announced that 7,846,646 warrants (LMND-WS) with an exercise price of $218.51 are set to expire on February 9, 2026, with NYSE trading suspension effective February 5, 2026.
NYSE
Lemonade, Inc. announced strong Q3 2025 results, showcasing accelerated growth in In Force Premium and significant progress towards profitability driven by AI efficiencies.
Better than expected
NYSE
Lemonade, Inc. announced the appointment of Prashant Ratanchandani as a Class II director to its Board, effective October 15, 2025.
NYSE
Lemonade, Inc. announced the appointment of Mr. Geoff Seeley to its Board of Directors, effective October 6, 2025.

Quarterly Earnings (10-Q)

See all →
NYSE
Lemonade, Inc. has entered into a New Business Financing Agreement with Hannover Re (Ireland) DAC, securing up to $250 million for sales and marketing growth, while also reporting a 124% increase in net earned premium for the quarter.
Capital raise
NYSE
Lemonade, Inc. reported a significant reduction in net loss and robust premium growth for the first quarter of 2026, driven by customer expansion and improved underwriting performance.
Better than expected
Capital raise
NYSE
Lemonade, Inc. reported a significant reduction in its net loss for the third quarter of 2025, driven by strong revenue growth and improved loss ratios, alongside a strategic shift in its reinsurance program.
Capital raise
Better than expected
NYSE
Lemonade, Inc. reported significant revenue growth and improved loss ratios in Q2 2025, driven by strong customer acquisition and higher premium per customer, despite an overall net loss.
Better than expected
Capital raise
NYSE
Lemonade Inc. saw a rise in gross written premium in Q1 2025, but net losses also increased due to higher expenses and catastrophe events.
Worse than expected
NYSE
Lemonade Inc. saw a revenue increase in Q3 2024, driven by customer growth and strategic reinsurance adjustments, while continuing to invest in sales and marketing.
Worse than expected

Annual Reports (10-K)

NYSE
Lemonade, Inc. announced significant revenue and customer growth in its 2025 annual report, alongside a notable reduction in net losses, driven by AI-powered operations and strategic product expansion.
Better than expected
Capital raise
NYSE
Lemonade Inc. releases its 10-K filing, highlighting growth in customer base and in-force premium, while navigating challenges in profitability and regulatory landscapes.
NYSE
Lemonade, Inc.'s 10-K filing outlines the company's capital structure, including common and preferred stock details, warrant agreements, and investor rights.

Insider Trading (Form 4)

See all →
NYSE
John Sheldon Peters, Chief Insurance Officer of Lemonade, Inc., sold 11,000 shares of common stock on August 13, 2026 for $52.55 per share.
NYSE
John Sheldon Peters, Chief Insurance Officer of Lemonade, Inc., received 10,000 shares of common stock on July 27, 2026.
NYSE
Lemonade's Chief Financial Officer, Timothy E. Bixby, has sold a significant number of shares under a pre-arranged trading plan.
NYSE
Lemonade, Inc. Chief Insurance Officer John Peters sold 3,444 shares of common stock for $77,942 under a pre-arranged trading plan.
NYSE
Director Michael Eisenberg reported a gift of 5,000 shares of Lemonade, Inc. common stock.
NYSE
Lemonade, Inc. CFO Timothy Bixby sold 2,227 shares of common stock to satisfy tax withholding obligations related to RSU vesting.

Proxy Statements (Def-14A)

NYSE
Lemonade, Inc. has issued its 2026 proxy statement detailing the upcoming virtual annual meeting, director elections, and executive compensation advisory vote.
Better than expected
NYSE
Lemonade, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NYSE
Lemonade, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 4, 2025, to vote on director elections, auditor ratification, and executive compensation.
Better than expected
NYSE
Lemonade, Inc. has filed a definitive proxy statement with the SEC.
NYSE
Lemonade, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, to vote on director elections, ratification of the accounting firm, and executive compensation.

Schedule 13G - Passive Investments

See all →
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.0% of Lemonade, Inc. common stock as of June 30, 2026.
NYSE
The Vanguard Group has amended its Schedule 13G filing for Lemonade Inc., reporting 0% beneficial ownership due to an internal realignment.
Worse than expected
NYSE
JPMorgan Chase & Co. has reported a 5.9% beneficial ownership stake in insurance technology company Lemonade, Inc. as of December 31, 2025.
NYSE
SoftBank Group Capital Ltd has reported a reduction in its beneficial ownership of Lemonade, Inc. common stock to 4.8%, falling below the 5% threshold.
Worse than expected
NYSE
SoftBank Group Capital Ltd has disclosed an 8.1% beneficial ownership in Lemonade, Inc., holding 5,958,698 shares as of June 30, 2025.
NYSE
The Vanguard Group has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.49% in Lemonade Inc.'s common stock as of June 30, 2025.